Literature DB >> 2789236

Skin-isolated, community-acquired Staphylococcus aureus: in vitro resistance to methicillin and erythromycin.

N Ohana1, J Keness, E Verner, R Raz, D Rozenman, F Zuckerman.   

Abstract

During a 10-month period, skin culture specimens were taken from 1680 healthy outpatients with a variety of community-acquired skin infections. Staphylococcus aureus was found in 1035 (61.6%) of these patients. In vitro resistance to methicillin and erythromycin was 1.0% and 42.9%, respectively. Resistance rates to erythromycin in patients with furunculosis and impetigo were 51.5% and 26.2%, respectively (p less than 0.001). The emergence of erythromycin-resistant strains may be the result of widespread use of this drug in our geographic area. There is also the possibility that certain bacteriologic features associated with erythromycin resistance may foster the development of furunculosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789236     DOI: 10.1016/s0190-9622(89)70223-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Comparative studies of cefprozil in the management of skin and soft-tissue infections.

Authors:  T Nolen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-10       Impact factor: 3.267

2.  Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.

Authors:  J P Guggenbichler; A Georgopoulos; P Scharrer; C Kobilansky; J Mühlbacher; M Georgopoulos; M P Dierich
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

3.  Carriage of methicillin-resistant Staphylococcus aureus by non-hospitalized subjects in Israel.

Authors:  M Dan; Y Moses; F Poch; J Asherov; R Gutman
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

4.  The clinical spectrum and antibiotic sensitivity patterns of staphylococcal pyodermas in the community and hospital.

Authors:  Shireen Furtado; Ramesh M Bhat; B Rekha; D Sukumar; Ganesh H Kamath; Jacintha Martis; B Nandakishore
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.